BACKGROUND: The aim of this study was to prospectively screen patients with a positive family history of carcinoid small intestine neuroendocrine tumors (SI-NETs) to elucidate the benefits of early detection and operative intervention. METHODS: A single-center, prospective trial was conducted from 2008 to 2014 that evaluated patients with 2 or more blood relatives with carcinoid SI-NETs. All eligible patients were screened with urine/serum biochemistries and various imaging modalities. Operative intervention was elected in patients found to have at least 1 positive diagnostic study. RESULTS: Twenty-nine patients from 13 families had occult carcinoid SI-NETs (15 female, 14 male). Twenty-four of the 29 patients (83%) had multifocal disease found in either the distal jejunum or ileum. On average, 75.9 cm (range, 13-195) of bowel was resected in 1 segment. Three patients were found to have stage IV disease at operation. All stage I-IIIB patients who had R0 resections have remained disease-free, with a median follow-up of 35 months. CONCLUSION: Familial carcinoid SI-NETs often are asymptomatic and can be diagnosed with aggressive screening. With early detection, there may be a window of opportunity for operative resection to change the natural history of this disease and even prove to be curative. Published by Elsevier Inc.
BACKGROUND: The aim of this study was to prospectively screen patients with a positive family history of carcinoid small intestine neuroendocrine tumors (SI-NETs) to elucidate the benefits of early detection and operative intervention. METHODS: A single-center, prospective trial was conducted from 2008 to 2014 that evaluated patients with 2 or more blood relatives with carcinoid SI-NETs. All eligible patients were screened with urine/serum biochemistries and various imaging modalities. Operative intervention was elected in patients found to have at least 1 positive diagnostic study. RESULTS: Twenty-nine patients from 13 families had occult carcinoid SI-NETs (15 female, 14 male). Twenty-four of the 29 patients (83%) had multifocal disease found in either the distal jejunum or ileum. On average, 75.9 cm (range, 13-195) of bowel was resected in 1 segment. Three patients were found to have stage IV disease at operation. All stage I-IIIB patients who had R0 resections have remained disease-free, with a median follow-up of 35 months. CONCLUSION:Familial carcinoid SI-NETs often are asymptomatic and can be diagnosed with aggressive screening. With early detection, there may be a window of opportunity for operative resection to change the natural history of this disease and even prove to be curative. Published by Elsevier Inc.
Authors: Klaas P Koopmans; Elisabeth G E de Vries; Ido P Kema; Philip H Elsinga; Oliver C Neels; Wim J Sluiter; Anouk N A van der Horst-Schrivers; Pieter L Jager Journal: Lancet Oncol Date: 2006-09 Impact factor: 41.316
Authors: Yoshitatsu Sei; Xilin Zhao; Joanne Forbes; Silke Szymczak; Qing Li; Apurva Trivedi; Mark Voellinger; Grishma Joy; Jianying Feng; Millie Whatley; MaryPat Sussex Jones; Ursula L Harper; Stephen J Marx; Aradhana M Venkatesan; Settara C Chandrasekharappa; Mark Raffeld; Martha M Quezado; Adeline Louie; Clara C Chen; Ramona M Lim; Richa Agarwala; Alejandro A Schäffer; Marybeth S Hughes; Joan E Bailey-Wilson; Stephen A Wank Journal: Gastroenterology Date: 2015-04-09 Impact factor: 22.682
Authors: James C Yao; Manal Hassan; Alexandria Phan; Cecile Dagohoy; Colleen Leary; Jeannette E Mares; Eddie K Abdalla; Jason B Fleming; Jean-Nicolas Vauthey; Asif Rashid; Douglas B Evans Journal: J Clin Oncol Date: 2008-06-20 Impact factor: 44.544
Authors: Manal M Hassan; Alexandria Phan; Donghui Li; Cecile G Dagohoy; Colleen Leary; James C Yao Journal: Int J Cancer Date: 2008-08-15 Impact factor: 7.396
Authors: Navid Hasani; Faraz Farhadi; Michael A Morris; Moozhan Nikpanah; Arman Rhamim; Yanji Xu; Anne Pariser; Michael T Collins; Ronald M Summers; Elizabeth Jones; Eliot Siegel; Babak Saboury Journal: PET Clin Date: 2022-01
Authors: R M Ruggeri; E Benevento; F De Cicco; B Fazzalari; E Guadagno; I Hasballa; M G Tarsitano; A M Isidori; A Colao; A Faggiano Journal: J Endocrinol Invest Date: 2022-08-30 Impact factor: 5.467
Authors: Magnus Kjellman; Ulrich Knigge; Staffan Welin; Espen Thiis-Evensen; Henning Gronbaek; Camilla Schalin-Jäntti; Halfdan Sorbye; Maiken Thyregod Joergensen; Viktor Johanson; Saara Metso; Helge Waldum; Jon Arne Søreide; Tapani Ebeling; Fredrik Lindberg; Kalle Landerholm; Goran Wallin; Farhad Salem; Maria Del Pilar Schneider; Roger Belusa Journal: Neuroendocrinology Date: 2020-07-28 Impact factor: 4.914